Europe Cannabis Industry & Marijuana Business News

Australian-grown medical cannabis clears key export hurdle for first time

Australia is one step closer to joining Canada and the Netherlands in the competitive medical cannabis export market. New South Wales-based Australian Natural Therapeutics Group said its domestically produced cannabis has been listed on the Register of Therapeutic Goods (ARTG), clearing one of the most important hurdles before exports can occur. Australian Natural Therapeutics Group […]

Read More

Tips for entering Europe’s medical cannabis market: Q&A with Christian Carlsen of Danish pharma firm NNE

Could medical cannabis be a growth engine for the pharmaceutical industry? A subsidiary of Danish pharmaceutical giant Novo Nordisk is betting the answer is yes. NNE A/S, a 1,000-person strong pharmaceutical engineering and advisory unit of Novo Nordisk A/S , has been counselling medical cannabis companies on establishing pharmaceutical-grade facilities in Europe and Asia. NNE’s cannabis […]

Read More

England’s health insurance has covered only 18 ‘unlicensed’ cannabis prescriptions

Since a new law took effect a year ago, England’s National Health Service (NHS) has reimbursed patients on only 18 occasions for “unlicensed” cannabis-based products that have not undergone clinical trials, according to government data. In the case of private prescriptions – which are paid out of pocket by patients – the number of prescriptions reached 104. The data […]

Read More

Proposed law in North Macedonia to allow cannabis flower export shelved

A North Macedonian draft bill that proposed modifications to the current medical cannabis framework has been removed from parliament’s agenda, according to Telma Television. The bill would have created a legal framework for the export of cannabis flower, which is currently not possible. That means local companies that have been stockpiling flower for export are going to […]

Read More

New UK guidelines recommend public insurance coverage for two GW Pharma cannabis medicines, plus a synthetic cannabinoid

New British guidelines for the first time recommend that two plant-based cannabis medicines – Sativex and Epidiolex – be covered through the United Kingdom’s National Health Service (NHS), a significant step that is likely to boost sales of both products. Health regulators also are recommending the NHS make available a synthetic cannabinoid known as nabilone. […]

Read More

Portugal tries to position itself as Europe’s top medical cannabis exporter, but companies face challenges

Portugal is gearing up to become a medical marijuana production powerhouse serving growing European markets. But as access to capital tightens in the global cannabis industry, companies wanting to set up operations in Portugal could have challenges to secure the necessary funds for their ambitious plans. Only a handful of firms are currently fully operational and […]

Read More

Italy cancels one of Aurora’s three cannabis supply lots

One of the three lots Canada’s Aurora Cannabis won in July to supply the Italian market has been canceled, Italy’s minister of health explained in a parliamentary inquiry this week, citing noncompliance with European Union Good Manufacturing Practice (GMP) standards. In July, Alberta-based Aurora was the sole winner of the contract after all other bidders were disqualified. […]

Read More

Danish medical cannabis sales stall on supply, price issues

Denmark’s medical cannabis pilot program saw virtually no quarter-over-quarter growth in the first half of 2019, according to new Danish Health Authority data. Experts say the market was hampered by a combination of prohibitively priced imports and supply issues. In the second quarter, 1,844 cannabis prescriptions were redeemed by 1,045 patients under Denmark’s four-year medical […]

Read More

North Macedonia’s medical cannabis overhaul would allow flower exports – but also create entry hurdles

Medical cannabis regulations in North Macedonia – a small but promising market – are likely to undergo significant changes before the end of 2019, allowing the export of flower for the first time but also raising barriers to entry for prospective businesses. The government of Prime Minister Zoran Zaev sent a draft bill to the Parliament […]

Read More

Gibraltar expands medical cannabis market beyond just CBD

Two years after Gibraltar legalized CBD, the tiny British Overseas Territory located on Spain’s south coast widened the range of cannabinoids available in the local market. The move could create limited opportunities for medical marijuana companies looking for an entry point into the European market, Brexit notwithstanding. “The new legislation covers a wider range of products […]

Read More

New data reveals top medical conditions for which cannabis is reimbursed in Germany

The German government disclosed the six most-reported diagnoses for which medical cannabis has been prescribed and covered by statutory health insurers (GKV), with pain No. 1 followed by a muscle condition known as spasticity. The data is based on an ongoing government survey involving 6,538 patients, as of September. The information was disclosed in a reply to a […]

Read More